Table 6

- Variant characteristics, clinical presentation, and MLS scores of 13 highly suspected children to have Wilson disease with a single heterozygous deleterious variant.

Patients’ IDsNucleotide changeCodon changeVariant effectVariant classificationPresentationMLS
Before NGSAfter NGS
5c.3741-3742dupCAp.Lys1248ThrfsTer83FrameshiftPathogenicHepatic45
6c.1745-1746delTAp.Ile582ArgfsTer25FrameshiftPathogenicMixed34
15c.2513delAp.Lys838SerfsTer35FrameshiftPathogenicHepatic23
16c.314C>Ap.Ser105TerStop-gainPathogenicHepatic56
17c.3895C>Tp.Leu1299pheMissensePathogenicHepatic45
22c.3836A>Gp.Asp1279GlyMissensePathogenic/likely pathogenicHepatic23
25c.4022G>Ap.Gly1341AspMissensePathogenicMixed34
27c.3263T>Ap.Leu1088TerStop-gainPathogenicNeuropsychiatric23
29c.2606G>Ap.Gly869GluMissenseVUS/Likely pathogenicHepatic34
52c.2000T>Ap.Leu667TerStop-gainPathogenic/likely pathogenicHepatic45
55c.3646G>Ap.Val1216MetMissensePathogenic/Likely pathogenicAsymptomatic34
56c.2532delAp.Val845SerfsTer28FrameshiftPathogenicHepatic23
57c.4022G>Ap.Gly1341AspMissensePathogenicHepatic23

ID: identification, MLS: modified Leipzig score, NGS: next-generation sequencing